Cat. No.
MABL-3917
Application
in vivo, SPR, therapeutic, ELISA
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
BIWA‑4 (Bivatuzumab)
From
Recombinant Antibody
Specificity
The antibody is specific for CD44v6. The antibody recognizes an epitope encoded by variant exon v6 of CD44. CD44v6 is a tumor‑associated antigen abundantly expressed in head and neck squamous cell carcinomas (HNSCC) and in normal squamous epithelium.
Alternative Names
CD44 antigen; CDw44; Epican; Extracellular matrix receptor III; ECMR‑III; GP90 lymphocyte homing/adhesion receptor; HUTCH‑I; Heparan sulfate proteoglycan; Hermes antigen; Hyaluronate receptor; Phagocytic glycoprotein 1; PGP‑1; Phagocytic glycoprotein I; PGP‑I; BIWA 4
UniProt
P16070
Immunogen
The antibody is the humanized version of the murine BIWA‑1.
Application Notes
The binding affinity of the antibody to CD44v6 was measured by surface plasmon resonance. The antibody demonstrated specific tumor localization when co‑administered with another antiCD44v6 antibody in mice (Verel et al., 2002; PMID: 11992408). The specificity of the humanized version was confirmed by ELISA (Kd=3.4 nM). In vivo experiments in mice showed good therapeutic efficacy, favorable biodistribution, and strong tumor uptake, with ¹⁸⁶Re‑labeled BIWA 4 treatment resulting in decreased tumor volume (US6972324B2). The radiolabeled humanized antibody was also evaluated in a clinical trial in patients with advanced squamous cell carcinoma of the head and neck, demonstrating promising antitumor activity (Börjesson et al., 2003; PMID: 14506195). This antibody was successfully used for immunohistochemistry on formalin‑fixed, paraffin‑embedded tissue sections to detect CD44v6 expression in squamous cell carcinomas of the head and neck, lung, esophagus, cervix, and vulva, as well as in selected normal tissues such as skin, tonsil, and squamous epithelium of the cervix and cornea. In flow cytometry, it specifically stained CD44v6‑positive tumor cell lines, including A431 and FaDu. The antibody efficiently internalized upon binding to CD44v6‑positive cells and exhibited selective tumor uptake in xenograft and clinical localization studies (Tijink et al., Clin. Cancer Res., 2006).
Antibody First Published
/
Note on publication
/
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.


